News & Insights
BeaconOne Joins JP Morgan Healthcare Conference
Our Managing Partner Thomas Goss attended the 42nd annual JP Morgan Healthcare conference in San Francisco, California to discuss global...
About BeaconOne Healthcare Partners®
We have supported medical technology innovators and investors across sectors (medical device, diagnostics, and biopharmaceuticals) through hundreds of assignments, providing guidance on their most complex business decisions.
Our teams use an integrated and strategic approach to characterize market opportunities; this approach includes a rigorous analysis of market need, value proposition, evidence requirements, reimbursement and market access, and health economics.
We often work at the convergence of technology approaches – for example, AI-enabled software or other digital solutions with medical devices, tools and equipment, advanced diagnostic technologies, and biopharmaceuticals.
Leadership
Tom Goss
Managing Partner and Co-Founder
- 30+ Years Life Sciences Strategy Consulting Experience
- Current CMS MEDCAC Appointee
- Global Health Economic And Value Communication Lead At Veranex & BHA; Global Market Access Consulting Lead At Covance
- Extensive Experience With Medical Devices, Diagnostics And Biopharmaceuticals
- Led Numerous Client Interactions With CMS, To Support NTAP, Pass-Through, ICD-10 And HCPCS Processes
- Numerous Peer-Reviewed Publications Addressing Value Of Healthcare Innovations And Impact Of Policy On Healthcare Innovation
Rob Wenthold
Managing Partner and Co-Founder
- 20+ years life sciences strategy consulting experience
- Global MedTech expertise
- Global reimbursement and market access lead at Veranex
- International lead at Boston Healthcare
- Industry speaker and moderator
- NIH biomedical research
Our Difference
Consulting Experience: In consulting, there is no substitute for consulting experience. The two Founders were executives and practice leaders at prior consultancies and combined bring decades of global consulting experience, serving a wide variety of clients ranging from start-ups to large multinational companies, investors and sovereign wealth funds, foreign trade and investment groups (or associations) seeking access to the U.S. healthcare market, and healthcare providers.
Global Commitment: We work with in-country experts with extensive experience to ensure that a thorough understanding of subtle, but important local market dynamics are considered when analyzing a business opportunity to deliver top-tier quality to our clients.
Payer Focus: Everything we do integrates the payer and financial risk holder perspective, as they are crucial to understanding commercial success. Our global team has access to payers and financial risk holders, as well as key opinion leaders and other clinical experts (or stakeholders) to inform our analysis.
Our History
The two co-founders of BeaconOne Healthcare Partners have worked together for the last 20 years, at three different life sciences strategy consulting firms. Most of this time was at Boston Healthcare Associates (BHA), a family-owned, boutique firm, where both Rob and Tom became long-term, trusted members of the executive team until the Company’s acquisition in 2021. During their tenure, BHA expanded its services, headcount, and geographic footprint. Though smaller in size than many of its competitors, BHA established a global reputation for high quality and excellence, particularly in MedTech.
The Founder and CEO of BHA empowered the team to innovate and think creatively when encountering growth opportunities. He would instruct his team to “go long and get open”, an old football saying essentially meaning that while playbook development may be ongoing, we can make optimal progress by putting our best talent in a position to succeed . This philosophy conveyed and sparked collaboration and trickled down throughout the organization, leading to an entrepreneurial and close-knit team culture, as all employee contributions were valued and recognized. This mindset also extended to client relationships, where novel approaches and extra steps were encouraged in client partnerships.
The success of BHA led to its eventual acquisition; however this way of conducting business remains a part of Tom and Rob’s DNA and carries over to their everyday approach to business today. BeaconOne Healthcare Partners was established to create a winning team environment and commitment to excellence built around these core drivers of client and employee satisfaction.
BeaconOne Healthcare Partners® Services
BeaconOne Healthcare Partners® provides services to the medical device, diagnostic, and pharmaceutical industries. We believe integrating market landscape, value, evidence, reimbursement and market access, and health economics perspectives is essential to providing a comprehensive understanding of business risk and opportunity. It requires specialized expertise.
BeaconOne Healthcare Partners® services take a strategic, multidisciplinary approach to these independent but related workstreams to understand real business and investment impact, whether it is shaping the value of a potential large acquisition/investment, pursuing a new market/application, tiering global geographies for market attractiveness, designing a robust clinical development program that will address the needs of both regulators (for approval) and payers (for coverage and reimbursement), or providing a market access roadmap to optimize adoption and penetration.
We bring established research approaches and frameworks we’ve developed through our experience with hundreds of prior assignments and offer scientific research for life sciences companies, organizations, and institutions in the fields of health economics, outcomes research, epidemiological studies, payer research, and market access.
BeaconOne Healthcare Partners® services include:
Market Opportunity and Landscape
Value Proposition and Insights
Market Access Strategy
Evidence Planning and Synthesis
Health Economics and Value Communication
Market Opportunity and Landscape
- Market analysis and research
- Market landscape and assessment
- Multi-stakeholder needs assessment
- Portfolio assessment and prioritization
- Opportunity prioritization for technology platforms
- Payer trends analysis
- Policy monitoring
- Evidence landscape assessment
- Patient journey
Value Proposition and Insights
- Business marketing consulting
- Strategic business and public policy consulting
- Market research and business analyses
- Competitor analysis
- Payer and provider value proposition assessment and development
- Value message testing
- Message-specific evidence gap assessment
Market Access Strategy
- Payer / HTA evidence gap assessment and development strategy
- Reimbursement or market access landscape and strategy
- Market access launch plan and roadmap
- Global market prioritization and launch sequencing
- Payer and clinician advisory boards
Evidence Planning and Synthesis
- Multi-stakeholder needs assessment
- Evidence gap assessment and development strategy (including RWE)
- Integrating evidence development strategy into clinical development plan
- Evidence plan validation with payers and clinicians
Health Economics and Value Communication
- Trial-based health economic analysis
- Claims analysis
- Literature review
- Economic model development
- Value communication tools (e.g., dossier, deck, brief, VAC PAC, conference presentations, and publications)
- Burden of illness studies
- Observational studies (e.g., Time and Motion)